Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × PSMA-BCH × Gastrointestinal × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Metastasis Colon Cancer 1

Interventions

Oxaliplatin 1230 Fluorouracil 1151 Capecitabine 941 Gemcitabine 906 Leucovorin 821 Irinotecan 714 Bevacizumab 697 Cisplatin 582 Radiotherapy 482 Cetuximab 408 pembrolizumab 377 Paclitaxel 342 Nivolumab 286 Drug Therapy 274 130-nm albumin-bound paclitaxel 269 Docetaxel 260 S 1 (combination) 244 Sorafenib 241 Folfox protocol 229 Albumin-Bound Paclitaxel 213 durvalumab 188 apatinib 182 Surgical Procedures, Operative 181 tislelizumab 172 sintilimab 172 lenvatinib 172 Radiosurgery 172 Carboplatin 162 Radiation 153 regorafenib 152

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06935149 2025-04-24

PSMA

Primo Biotechnology Co., Ltd

Phase 1 Not yet recruiting

Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡